Announcements Trials
Browse Landscape

Status

Completed 6Recruiting 2Withdrawn 1Unknown 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Breast 1

Conditions

Hematologic Neoplasms 1Heart Failure 1Cardiomyopathies 1Breast Neoplasms 1

Interventions

pembrolizumab 563Specimen Handling 493Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 405Radiotherapy 353Bevacizumab 314Gemcitabine 313Paclitaxel 298Biopsy 292Drug Therapy 284Blood Specimen Collection 248Capecitabine 246Oxaliplatin 241fludarabine 239Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 206Dexamethasone 188Radiosurgery 182Standard of Care 159Rituximab 159Pemetrexed 156Surgical Procedures, Operative 148atezolizumab 146durvalumab 145Leucovorin 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Electronic Health Records × Clear all
NCT04888338 2026-04-16

Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies

M.D. Anderson Cancer Center

Recruiting
100 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT05507879 2026-02-10

TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer

Mayo Clinic

Recruiting
200 enrolled
Breast

Breast Neoplasms, Heart Failure, Cardiomyopathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡